Mrv0541 09041212572D 18 19 0 0 0 0 999 V2000 -0.6284 1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 0.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 0.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 2.1904 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.0701 1.1104 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.6411 1.9354 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0701 1.9354 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.3556 2.3479 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.6411 1.1104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3984 2.9750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 0.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 2.3479 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 3.1729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9584 2.3194 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0701 0.2854 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.2795 2.6769 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 1.5229 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.8253 2.9799 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 4 1 1 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 7 5 1 0 0 0 0 8 6 1 0 0 0 0 8 7 1 0 0 0 0 9 2 1 0 0 0 0 9 3 1 0 0 0 0 9 6 1 0 0 0 0 4 10 1 6 0 0 0 5 11 1 1 0 0 0 7 12 1 6 0 0 0 8 13 1 1 0 0 0 4 14 1 1 0 0 0 5 15 1 6 0 0 0 6 16 1 1 0 0 0 7 17 1 1 0 0 0 8 18 1 6 0 0 0 M END > DB01816 > drugbank > [H][C@]1(O)CCN2C[C@]([H])(O)[C@@]([H])(O)[C@]([H])(O)[C@@]12[H] > InChI=1S/C8H15NO4/c10-4-1-2-9-3-5(11)7(12)8(13)6(4)9/h4-8,10-13H,1-3H2/t4-,5-,6+,7+,8+/m0/s1 > JDVVGAQPNNXQDW-TVNFTVLESA-N > C8H15NO4 > 189.209 > 189.100107973 > 5 > 28 > 0.9891788450793789 > 18.779314815643485 > 1 > 4 > 0 > 0 > (1S,6S,7R,8R,8aR)-octahydroindolizine-1,6,7,8-tetrol > -2.13 > -2.55449338 > 0.77 > 0 > 1 > 2 > 1 > 13.937923280643474 > 12.890403197844769 > 8.961021131034355 > 84.16000000000001 > 44.4357 > 0 > 1 > 1.11e+03 g/l > biotin > 0 > DB01816 > EXPT01055 > experimental > Castanospermine > (1S-(1α,6β,7α,8β,8αβ))-octahydro-1,6,7,8-indolizinetetrol; (1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine; 1,6,7,8-tetrahydroxyoctahydroindolizine $$$$